Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Reven Holdings
AddedFeb 17, 2024
UpdatedJun 18, 2026
Reven Holdings

Reven Holdings

Public

Reven Pharmaceuticals: A global healthcare leader providing advanced treatments for vascular and metabolic conditions since 1999.

HQ
Broomfield, CO, US
Founded
1999
Overview
Compare
Fundraising
Employees
Website

Reven Holdings, founded in 1999 and headquartered in Golden, Colorado, is a clinical-stage company dedicated to providing advanced treatments for vascular and metabolic-related conditions. The company's core mission is to develop innovative solutions that enhance patient recovery and improve outcomes for conditions such as critical limb ischemia, peripheral arterial disease, coronary artery disease, and endothelial dysfunction. Reven Pharmaceuticals positions itself as a global healthcare leader with a strong focus on delivering cutting-edge products to address these serious health issues.

Notable figures affiliated with Reven Holdings include its leadership team, which comprises experienced professionals in healthcare and pharmaceuticals. The company has garnered attention from significant investors in the biotech sector, contributing to its growth and development. Key achievements include advancing its pipeline of therapeutic products through various stages of clinical trials, demonstrating potential efficacy in treating complex vascular and metabolic conditions. Reven's impact is marked by its commitment to improving patient care and its ongoing contributions to medical research and innovation.

Reven Holdings - Similar Companies

Revvity logo

Revvity

Revagenix logo

Revagenix

revagenix.com

Rivus Pharmaceuticals logo

Rivus Pharmaceuticals

rivuspharma.com

Revance Therapeutics logo

Revance Therapeutics

revance.com

Revive Biotechnology logo

Revive Biotechnology

revivebiotech.com

Traverse Vascular logo

Traverse Vascular

Revalesio logo

Revalesio

revalesio.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Revel Pharmaceuticals logo

Revel Pharmaceuticals

TheraVasc logo

TheraVasc

Reviticell Holdings logo

Reviticell Holdings

Trevena logo

Trevena

Renerva logo

Renerva

renerva.com

Riparian Pharmaceuticals logo

Riparian Pharmaceuticals

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Reven Holdings - Quick Facts

Who are Reven Holdings' competitors?

Companies similar to Reven Holdings include Revvity, Revagenix, Rivus Pharmaceuticals and Revance Therapeutics.

When was Reven Holdings founded?

Reven Holdings was founded in 1999.

Where is Reven Holdings' headquarters located?

Reven Holdings' headquarters is located in Broomfield, CO, US.

When was Reven Holdings' last funding round?

Reven Holdings' most recent funding round was for $23M (USD) in January 2019.

How much has Reven Holdings raised to-date?

As of Jan 1, 2019, Reven Holdings has raised a total of $67.3M (USD).

How many employees does Reven Holdings have?

Reven Holdings has 6 employees as of Feb 5, 2024.

Reven Holdings - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Treatments
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified